共 50 条
- [1] Patient experiences with tissue-based genomic testing during active surveillance for prostate cancer BJUI COMPASS, 2024, 5 (01): : 142 - 149
- [2] PATIENT AND GEOGRAPHIC FACTORS ASSOCIATED WITH EARLY ADOPTION OF TISSUE-BASED GENOMIC TESTING FOR PROSTATE CANCER JOURNAL OF UROLOGY, 2023, 209 : E594 - E594
- [3] IMPACT OF TISSUE-BASED GENOMIC TESTING ON PAYMENTS FOR PROSTATE CANCER CARE JOURNAL OF UROLOGY, 2023, 209 : E213 - E214
- [4] FREQUENCY OF PSA TESTING IN MEN ON ACTIVE SURVEILLANCE FOR PROSTATE CANCER. JOURNAL OF UROLOGY, 2015, 193 (04): : E755 - E755
- [5] Prognostic Genomic Tissue-Based Biomarkers in the Treatment of Localized Prostate Cancer JOURNAL OF PERSONALIZED MEDICINE, 2022, 12 (01):
- [7] Incorporation of tissue-based genomic biomarkers into localized prostate cancer clinics BMC MEDICINE, 2016, 14
- [9] Active treatment or surveillance in prostate cancer. PROGRES EN UROLOGIE, 2007, 17 (01): : 98 - 98